Search

Author/Creator Cunningham, Jonathan W

1. Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials. Issue 10244 (11th July 2020)

Authors:
Vaduganathan, Muthiah; Claggett, Brian L; Jhund, Pardeep S; Cunningham, Jonathan W; Pedro Ferreira, João; Zannad, Faiez; Packer, Milton; Fonarow, Gregg C; McMurray, John J V; Solomon, Scott D
Journal:
Lancet
Issue:
Volume 396:Issue 10244(2020)
Page Start:
121
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48. Issue 7 (28th December 2021)

Authors:
Bonaca, Marc P; Antman, Elliott M; Cunningham, Jonathan W; Wiviott, Stephen D; Murphy, Sabina A; Halperin, Jonathan L; Weitz, Jeffrey I; Grosso, Michael A; Lanz, Hans J; Braunwald, Eugene; Giugliano, Robert P; Ruff, Christian T
Journal:
European heart journal
Issue:
Volume 8:Issue 7(2022)
Page Start:
695
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗